Pharma company Biocon is set to announce its financial results for the quarter ended September 30, 2024, tomorrow, October 1 ...

Despite Biocon's assurances that the findings would not impact its business, investor sentiment appeared cautious.

Bangalore: Biocon has announced that the U.S Food and Drug Administration (US FDA) has concluded a surveillance inspection ...

Shares of Biocon have surged 44% in 2024 to date and 30% over the past two years, with the company currently holding a market ...

Biocon has not disclosed the specifics of the observations, but in an exchange filing, the company said that it would address ...

The scope of the inspection included one Drug Substance and one Drug Product manufacturing unit, a Medical Device Assembly ...

Biocon Ltd has entered a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to market GLP-1 ...

The inspection, which took place between September 23 and September 27, 2024, concluded with 4 observations from the ...

Karnataka: Biocon Biologics has announced that the US Food and Drug Administration (USFDA) has completed a cGMP inspection at ...

The US Food and Drug Administration (USFDA) conducted a surveillance inspection of the API facility (Site 2), located at ...

Biocon's Bengaluru-based API facility received four observations from the USFDA following an inspection. The company plans to ...